End-of-day quote
Korea S.E.
03:30:00 29/05/2024 am IST
|
5-day change
|
1st Jan Change
|
37,100
KRW
|
-3.89%
|
|
-1.33%
|
0.00%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Capitalization
1 |
5,54,474
|
5,54,474
|
-
|
Enterprise Value (EV)
1 |
5,54,474
|
5,54,474
|
5,54,474
|
P/E ratio
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
109
x
|
61.6
x
|
26.7
x
|
EV / Revenue
|
109
x
|
61.6
x
|
26.7
x
|
EV / EBITDA
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
14,945
|
14,945
|
-
|
Reference price
2 |
37,100
|
37,100
|
37,100
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Net sales
1 |
5.1
|
9
|
20.8
|
EBITDA
|
-
|
-
|
-
|
EBIT
1 |
-6.5
|
-5.1
|
1.8
|
Operating Margin
|
-127.45%
|
-56.67%
|
8.65%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 42Cr | | -14.53% | 2.05TCr | | +4.99% | 1.89TCr | | +6.37% | 1.4TCr | | -18.11% | 205.69Cr | | +1.28% | 176.11Cr | | +12.11% | 140.92Cr | | +10.70% | 57Cr | | +71.63% | 20Cr | | +21.36% | 9.58Cr |
Medical Prosthetics
|